Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × TP protocol × Head & Neck × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Thoracic 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 Breast 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 118 Radiotherapy 57 Fluorouracil 41 Radiotherapy, Intensity-Modulated 40 Docetaxel 35 Gemcitabine 31 Cetuximab 28 Carboplatin 23 Capecitabine 20 pembrolizumab 19 Drug Therapy 15 Paclitaxel 13 toripalimab 12 Surgical Procedures, Operative 9 Nivolumab 9 nimotuzumab 8 camrelizumab 8 Magnetic Resonance Spectroscopy 8 Chemoradiotherapy 8 nedaplatin 7 Methotrexate 7 tislelizumab 6 Standard of Care 6 Specimen Handling 6 Radiation 6 Platinum 6 Neoadjuvant Therapy 6 Iodine-131 6 Induction Chemotherapy 6 Gabapentin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01126216 2021-05-04

Paccis-RCT

University of Erlangen-Nürnberg Medical School

Phase 3 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡